CD274 and triple-negative breast carcinoma: For example, EVs from adipose tissue-derived MSCs (AD-MSCs) modified to express miRNA-424 can delay the progression of triple-negative breast cancer by blocking programmed cell death protein 1/programmed cell death 1 ligand 1 (PD-1/PD-L1) [153].